A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objectives: Chronic constipation in diabetes mellitus is associated with colonic motor dysfunction and is managed with laxatives. Cholinesterase inhibitors increase colonic motility. This study evaluated the effects of a cholinesterase inhibitor on gastrointestinal and colonic transit and bowel function in diabetic patients with constipation. Design: After a 9-day baseline period, 30 patients (mean±SEM age 50±2 years) with diabetes mellitus (18 type 1, 12 type 2) and chronic constipation without defaecatory disorder were randomised to oral placebo or pyridostigmine, starting with 60 mg three times a day, increasing by 60 mg every third day up to the maximum tolerated dose or 120 mg three times a day; this dose was maintained for 7 days. Gastrointestinal and colonic transit (assessed by scintigraphy) and bowel function were evaluated at baseline and the final 3 and 7 days of treatment, respectively. Treatment effects were compared using analysis of covariance, with gender, body mass index and baseline colonic transit as covariates. Results: 19 patients (63%) had moderate or severe autonomic dysfunction; 16 (53%) had diabetic retinopathy. 14 of 16 patients randomised to pyridostigmine tolerated 360 mg daily; two patients took 180 mg daily. Compared with placebo (mean±SEM 1.98±0.17 (baseline), 1.84±0.16 (treatment)), pyridostigmine accelerated (1.96±0.18 (baseline), 2.45±0.2 units (treatment), p<0.01) overall colonic transit at 24 h, but not gastric emptying or small-intestinal transit. Treatment effects on stool frequency, consistency and ease of passage were significant (p≤0.04). Cholinergic side effects were somewhat more common with pyridostigmine (p=0.14) than with placebo. Conclusions: Cholinesterase inhibition with oral pyridostigmine accelerates colonic transit and improves bowel function in diabetic patients with chronic constipation. Clinical trial registration number: TrialRegNo (NCT 00276406).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
A placebo-controlled trial of prucalopride for severe chronic constipation
Camilleri, M., Kerstens, R., Rykx, A., & Vandeplassche, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800670 · Cited by 576 · cited 1×
“8 CSBM for 4 mg).(34) Similarly to previous studies, patients had a spectrum of complications of DM, type and severity of autonomic dysfunctions, and disturbances of GI and colonic transit.”
MethodSelf-citationPrather, C. M., Camilleri, M., Zinsmeister, A. R., McKinzie, S., & Thomforde, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70251-4 · Cited by 410
Self-citationGastrointestinal tract symptoms among persons with diabetes mellitus in the community
Maleki, D., Locke, G. R., Camilleri, M., Zinsmeister, A. R., Yawn, B. P., Leibson, C., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2808 · Cited by 282
Self-citationDiabetic gastroparesis: what we have learned and had to unlearn in the past 5 years: Figure 1
Kashyap, P., & Farrugia, G. (2010) · Gut · doi:10.1136/gut.2009.199703 · Cited by 175
Autonomic dysfunction in gastrointestinal motility disorders
Bharucha, A. E., Camilleri, M., Low, P. A., & Zinsmeister, A. R. (1993) · Gut · doi:10.1136/gut.34.3.397 · Cited by 141 · cited 1×
“40 Nearly two-thirds of the patients with diabetes randomised in our study had moderate-severe autonomic dysfunctions affecting one or more components of the autonomic nervous system, which is very similar to the prevalence of autonomic dysfunction in a cohort of patients with DM and upper GI motility disorders previo…”
ResultSelf-citation
Cited by
American Gastroenterological Association Technical Review on Constipation
Bharucha, A. E., Pemberton, J. H., & Locke, G. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.028 · Cited by 909
Self-citationBharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Self-citationSharma, A., Rao, S. S. C., Kearns, K., Orleck, K. D., & Waldman, S. A. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16369 · Cited by 84
Taba Taba Vakili, S., Nezami, B. G., Shetty, A., Chetty, V. K., & Srinivasan, S. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12630 · Cited by 63
Gastrointestinal autonomic neuropathy in diabetes
Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102718 · Cited by 38
Metadata
- Authors
- Bharucha, A. E., Low, P., Camilleri, M., Veil, E., Burton, D., Kudva, Y., Shah, P., Gehrking, T., & Zinsmeister, A. R.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-06-07
- Volume
- 62
- Issue
- 5
- Pages
- 708-715
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2100894191
- Cited by
- 98
- References
- 7
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. https://app.cochat.ai/papers/10.1136/gutjnl-2012-302483
- The paper
- Bharucha, A. E., Low, P., Camilleri, M., Veil, E., Burton, D., Kudva, Y., Shah, P., Gehrking, T., & Zinsmeister, A. R. (2013). A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. https://doi.org/10.1136/gutjnl-2012-302483
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.